Chinmaya Rath - 23 Mar 2023 Form 3 Insider Report for GLYCOMIMETICS INC (GLYC)

Role
SVP and Chief Business Officer
Signature
/s/ Brian F. Leaf, as attorney-in-fact
Issuer symbol
GLYC
Transactions as of
23 Mar 2023
Net transactions value
$0
Form type
3
Filing time
31 Mar 2023, 16:36:25 UTC
Next filing
17 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding GLYC Common Stock 161,178 23 Mar 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding GLYC Employee Stock Option (right to buy) 23 Mar 2023 Common Stock 150,000 $3.48 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying this option will vest on February 10, 2024 and the remaining shares will vest in equal monthly installments over 36 months thereafter, subject to the Reporting Person's continued service with the Issuer through each such vesting date.